Home Research Staff Publications

Publications

Dr. Georgios Paslakis

Gilles M, Hentschel F, Paslakis G, Glahn V, Lederbogen F, Deuschle M. Visceral and Subcutaneous Fat in Patients Treated With Olanzapine: A Case Series. Clin Neuropharmacol. 2010 33(5):248-9. Epub 2010 Sep 6.
Gilles M, Paslakis G, Heinrich A, Szostek A, Meyer P, Nees F, Rauschenberg J, Gröbner J, Krumm B, Semmler W, Flor H, Meyer-Lindenberg A, Deuschle M. A cross-over study of effects on the hypothalamus-pituitary-adrenal-(HPA-) axis and the sympathoadrenergic system in magnetic field strength exposure from 0 to 7 Tesla. Stress. 2013 16(2):172-80. Epub 2012 Aug 8..
Gronau W, Paslakis G, Lederbogen F, Weber-Hamann B, Gilles M, Schilling C, Deuschle M. Increased Platelet Count after Treatment with Venlafaxine or Mirtazapine in Depressed Patients. Pharmacopsychiatry. 2015 48(1):37-9. Epub 2014 Nov 17.
Heinrich A, Szostek A, Meyer P, Nees F, Rauschenberg J, Gröbner J, Gilles M, Paslakis G, Deuschle M, Semmler W, Flor H. Cognition and Sensation in Very High Static Magnetic Fields: A Randomized Case-Crossover Study with Different Field Strengths. Radiology. 2013 266(1):236-45. Epub 2012 Oct 22..
Heinrich A, Szostek A, Meyer P, Reinhard I, Gilles M, Paslakis G, Rauschenberg J, Gröbner J, Semmler W, Deuschle M, Meyer-Lindenberg A, Flor H, Nees F. Women are more strongly affected by dizziness in static magnetic fields of magnetic resonance imaging scanners. Neuroreport. 2014 25(14):1081-4. epub 2014 Aug 2.
Kopf D, Gilles M, Paslakis G, Medlin F, Lederbogen F, Lehnert H, Deuschle M. Insulin secretion and sensitivity after single-dose amisulpride, olanzapine or placebo in young male subjects: double blind, cross-over glucose clamp study. Pharmacopsychiatry. 2012 45(6):223-8.
Paslakis G, Bleich S, Frieling H, Deuschle M. [Epigenetic mechanisms in major depression]. Nervenarzt. 2011 82(11):1431-2, 1434-8.
Paslakis G, Blum WF, Deuschle M. Intranasal insulin-like growth factor I (IGF-I) as a plausible future treatment of depression. Med Hypotheses. 2012 79(2):222-5.
Paslakis G, Buchmann AF, Westphal S, Banaschewski T, Hohm E, Zimmermann US, Laucht M, Deuschle M. Intrauterine Exposure to Cigarette Smoke is Associated with Increased Ghrelin Concentrations in Adulthood. Neuroendocrinology. 2014 99(2):123-9. Epub 2014 May 8.
Paslakis G, Deuschle M, Thome J, Rüsse S, Kopf D. The differential effect of risperidone and olanzapine on insulin sensitivity after 3 weeks of treatment: a HOMA pilot study. Pharmacopsychiatry. 2012 45(3):96-9.
Paslakis G, Gass P, Deuschle M. [The role of the glutamatergic system in pathophysiology and pharmacotherapy for depression: preclinical and clinical data]. Fortschr Neurol Psychiatr. 2011 79(4):204-12.
Paslakis G, Gilles M, Deuschle M. Clinically relevant pharmacokinetic interaction between venlafaxine and bupropion: a case series. J Clin Psychopharmacol. 2010 30(4):473-4.
Paslakis G, Gilles M, Deuschle M. Pregabalin in the treatment of posttraumatic stress disorder: A case report. Prog Neuropsychopharmacol Biol Psychiatry. 2011 35(4):1160-1. Epub 2011 Feb 19.
Paslakis G, Gilles M, Frankhauser P, Lanczik O, Deuschle M, Frölich L, Müller FH, Kopf D. Two cases of primary hyperparathyroidism with depressive and cognitive symptoms. J Nutr Health Aging. 2010 14(9):798-9.
Paslakis G, Gilles M, Lederbogen F, Schilling C, Scharnholz B, Deuschle M. The effect of a 4-week treatment with reboxetine on metabolic parameters of depressed inpatients. Eur Arch Psychiatry Clin Neurosci. 2011 261(3):173-7. Epub 2010 Oct 30.
Paslakis G, Gilles M, Meyer-Lindenberg A, Deuschle M. Oral administration of the NMDA receptor antagonist S-ketamine as add-on therapy of depression: a case series. Pharmacopsychiatry. 2010 43(1):33-5.
Paslakis G, Heuser I, Schweiger U, Deuschle M. A single DEX/CRH test in male drug-free depressed patients is associated with the clinical response to treatment with fluoxetine. J Psychiatr Res. 2010 44(16):1154-7. Epub 2010 May 5.
Paslakis G, Kiefer F, Diehl A, Alm B, Sobanski E. [Methylphenidate. Therapy option for adults with ADHD and comorbid substance use disorder?]. Nervenarzt. 2010 81(3):277-88.
Paslakis G, Kopf D, Westphal S, Gilles M, Lederbogen F, Hamann B, Heuser I, Deuschle M. Treatment with paroxetine, but not amitriptyline, lowers levels of lipoprotein(a) in patients with major depression. J Psychopharmacol. 2011 25(10):1344-6. Epub 2010 Oct 15.
Paslakis G, Krumm B, Gilles M, Schweiger U, Heuser I, Richter I, Deuschle M. Discrimination between patients with melancholic depression and healthy controls: Comparison between 24-h cortisol profiles, the DST and the Dex/CRH test. Psychoneuroendocrinology. 2011 36(5):691-8. epub 2010 Oct 27.
Paslakis G, Lecei O, Stalla GK, Landgraf R, Uhr M, Hamann B, Luppa P, Gilles M, Heuser I, Deuschle M. The effect of treatment with ketoconazole on central CRH systems of depressed patients. Hum Psychopharmacol. 2011 26(1):35-40. Epub 2011 Mar 11.
Paslakis G, Luppa P, Gilles M, Kopf D, Hamann-Weber B, Lederbogen F, Deuschle M. Venlafaxine and mirtazapine treatment lowers serum concentrations of dehydroepiandrosterone-sulfate in depressed patients remitting during the course of treatment. J Psychiatr Res. 2010 44(8):556-60. Epub 2009 Dec 21.
Paslakis G, Schredl M, Alm B, Sobanski E. [Adult Attention Deficit/Hyperactivity Disorder, Associated Symptoms and Comorbid Psychiatric Disorders: Diagnosis and Pharmacological Treatment.]. Fortschr Neurol Psychiatr. 2013 81(8):444-51. Epub 2013 Jul 17.
Paslakis G, Westphal S, Hamann B, Gilles M, Lederbogen F, Deuschle M. Unstimulated and glucose-stimulated ghrelin in depressed patients and controls. J Psychopharmacol. 2014 28(6):582-586. Epub 2014 Mar 26.
Schilling C, Blum WF, Heuser I, Paslakis G, Wudy SA, Deuschle M. Treatment with antidepressants increases insulin-like growth factor-I in cerebrospinal fluid. J Clin Psychopharmacol. 2011 31(3):390-2.


Zentralinstitut für Seelische Gesundheit (ZI) - https://www.zi-mannheim.de